Health & Fitness
Wed, April 24, 2013Tue, April 23, 2013Mon, April 22, 2013Sun, April 21, 2013Fri, April 19, 2013Thu, April 18, 2013Wed, April 17, 2013Tue, April 16, 2013Mon, April 15, 2013Fri, April 12, 2013Thu, April 11, 2013Wed, April 10, 2013Tue, April 9, 2013Mon, April 8, 2013Sat, April 6, 2013Fri, April 5, 2013Thu, April 4, 2013Wed, April 3, 2013Tue, April 2, 2013Mon, April 1, 2013Fri, March 29, 2013Thu, March 28, 201315 PM EDT
Published in Health and Fitness on Thursday, April 11th 2013 at 4:15 GMT, Last Modified on 2013-04-11 04:53:00 by Market Wire
April 11, 2013 07:00 ET
Implant Sciences to Host Conference Call Thursday, April 11 at 4:15 PM EDT
WILMINGTON, MA--(Marketwired - Apr 11, 2013) - Implant Sciences Corporation (
Company Conference Call
Management will host a conference call on Thursday, April 11, 2013 at 4:15 PM Eastern time to provide an update to investors. Following the Company's prepared remarks there will be a Q&A session. The call can be accessed by interested parties by dialing: 877-546-5020 within the U.S. or 857-244-7552 outside the U.S. and entering passcode 90133266. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins. A replay of the conference call will be available approximately two hours after the call for one month by dialing: 888-286-8010 within the U.S. or 617-801-6888 outside the U.S. and entering passcode 76845591. The conference call will also be available live over the Internet at the investor relations section of Implant Sciences' website at [ www.implantsciences.com ]. A replay of the webcast will be available for one month after the call.
About Implant Sciences
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company's QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at [ www.implantsciences.com ].
